At least one case report has demonstrated a robust clinical response due to the combination of bronchoscopic cryoablation and camrelizumab, a humanized monoclonal antibody against programmed cell death protein 1 (PD-1), in a patient with advanced sarcomatoid carcinoma of the lung (32). The gene discussed is PDCD1; the disease is lung sarcomatoid carcinoma.